BioInformatics
Industry, Regulators Move to Adopt Quality Standards
Harmonization spurs efforts to implement modern manufacturing systems and risk-management programs.
Date:
02/01/2007
, Publication:
Pharmaceutical Technology
, Author:
Jill Wechsler
http://www.pharmtech.com/pharmtech/article/articleDetail.jsp?id=400644
The HIT Revolution in Clinical Research
Disciplines such as systems biology, high-throughput screening, bioinformatics, and data visualization are beginning to show promise
Date:
02/01/2007
, Publication:
Applied Clinical Trials
, Author:
Paul Mattes
http://www.actmagazine.com/appliedclinicaltrials/article/articleDetail.jsp?id=4
Innovations in API Synthesis
As custom manufacturers gather for InformexUSA this month, strategies in asymmetric synthesis and catalysis prevail.
Date:
02/01/2007
, Publication:
Pharmaceutical Technology
, Author:
Patricia Van Arnum
http://www.pharmtech.com/pharmtech/article/articleDetail.jsp?id=400918
New drugs join guidelines for multiple myeloma
Multiple myeloma is the second most common form of hematologic cancer (non-Hodgkin's lymphoma is the first)...
Date:
01/22/2007
, Publication:
Drug Topics
, Author:
Jillene Magill-Lewis, R.Ph.
http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=398005
New Strategies for the CRO Sponsor Relationship
Drug developers balance on a knife's edge, trying to formulate innovative new compounds quickly that will survive late-stage clinical trials
Date:
01/01/2007
, Publication:
Pharmaceutical Technology
, Author:
Kaylynn Chiarello-Ebner
http://www.pharmtech.com/pharmtech/article/articleDetail.jsp?id=397031
Drug discovery down, despite quicker approvals
Still, according to Williams, the United States currently leads the world with nearly 3,000 new drugs in development...
Date:
12/11/2006
, Publication:
Drug Topics
, Author:
Heidi Belden, Pharm.D.
http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=389599
Pipeline-Rays of Light
This year's Pipeline Report profiles 32 compounds that are the early fruit of pharma's investment in targeted drug design.
Date:
12/01/2006
, Publication:
Pharmaceutical Executive
, Author:
Staff at Pharmaceutical Executive
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=389274
Therapeutic Equivalence-FDA Approved Drug Products with Therapeutic Equivalence Evaluations
Orange Book
Date:
11/17/2006
, Publication:
FDA-CDER
, Author:
FDA
http://www.fda.gov/cder/orange/default.htm
FDA Awards Contract to Assess Postmarketing Study Commitment Decision-Making Process
Analysis Will Lead To a More Standardized Approach
Date:
04/05/2006
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2006/NEW01350.html
FDA Unveils Critical Path Opportunities List Outlining Blueprint To Modernizing Medical Product Development by 2010
Biomarker Development and Clinical Trial Design Greatest Areas for Impact
Date:
03/16/2006
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/news/2006/NEW01336.html
< Previous
Page 2 of 5
Next >
Search returned 44 items.
|
Sponsored Links
Medical Marketing & Media is a monthly
to 14,000 healthcare marketing executives
www.medicalmarketingandmedia.com
This twice-monthly news magazine
reports on all phases of pharmacy
www.drugtopics.com
|